James Fetten

1.2k total citations
29 papers, 680 citations indexed

About

James Fetten is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, James Fetten has authored 29 papers receiving a total of 680 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 12 papers in Pulmonary and Respiratory Medicine and 7 papers in Surgery. Recurrent topics in James Fetten's work include Head and Neck Cancer Studies (7 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Lung Cancer Treatments and Mutations (4 papers). James Fetten is often cited by papers focused on Head and Neck Cancer Studies (7 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Lung Cancer Treatments and Mutations (4 papers). James Fetten collaborates with scholars based in United States, China and Switzerland. James Fetten's co-authors include Willi Kreis, Daniel R. Budman, V. Vinciguerra, Myron Susin, Savita Pahwa, Mark H. Kaplan, Steven L. Allen, Stuart M. Lichtman, Nathan H. Roy and Robert C. Gallo and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Immunology and Journal of the American College of Cardiology.

In The Last Decade

James Fetten

28 papers receiving 652 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James Fetten United States 14 267 214 136 106 99 29 680
Paresh Jain India 13 116 0.4× 65 0.3× 59 0.4× 128 1.2× 100 1.0× 41 478
Tibor Füle Hungary 15 107 0.4× 142 0.7× 126 0.9× 29 0.3× 147 1.5× 23 738
D. Rontogianni Greece 13 138 0.5× 77 0.4× 74 0.5× 51 0.5× 58 0.6× 32 427
Antonio Ramponi Italy 14 350 1.3× 111 0.5× 96 0.7× 74 0.7× 70 0.7× 37 1.0k
Katie Fain United States 4 647 2.4× 132 0.6× 131 1.0× 348 3.3× 130 1.3× 4 960
Bettien M. van Hemel Netherlands 16 201 0.8× 129 0.6× 302 2.2× 43 0.4× 28 0.3× 44 873
R Jlidi Tunisia 15 373 1.4× 107 0.5× 200 1.5× 16 0.2× 58 0.6× 79 819
Ren‐Ching Wang Taiwan 12 157 0.6× 77 0.4× 141 1.0× 105 1.0× 100 1.0× 53 481
Hans‐Georg Vogt Germany 10 150 0.6× 95 0.4× 93 0.7× 273 2.6× 78 0.8× 14 501
Carey Z. August United States 15 128 0.5× 109 0.5× 120 0.9× 38 0.4× 100 1.0× 31 527

Countries citing papers authored by James Fetten

Since Specialization
Citations

This map shows the geographic impact of James Fetten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Fetten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Fetten more than expected).

Fields of papers citing papers by James Fetten

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James Fetten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Fetten. The network helps show where James Fetten may publish in the future.

Co-authorship network of co-authors of James Fetten

This figure shows the co-authorship network connecting the top 25 collaborators of James Fetten. A scholar is included among the top collaborators of James Fetten based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James Fetten. James Fetten is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Desîlets, Antoine, David G. Pfister, Sarah Stein, et al.. (2024). A phase 1 study of concurrent cabozantinib and cetuximab in recurrent or metastatic head and neck squamous cell cancer. Oral Oncology. 154. 106861–106861. 4 indexed citations
2.
Campbell, Thomas M., Lisa Blanchard, Nellie Wixom, et al.. (2024). A whole food, plant-based randomized controlled trial in metastatic breast cancer: feasibility, nutrient, and patient-reported outcomes. Breast Cancer Research and Treatment. 206(2). 273–283. 11 indexed citations
3.
Campbell, Thomas M., Lisa Blanchard, Nellie Wixom, et al.. (2024). A whole-food, plant-based randomized controlled trial in metastatic breast cancer: weight, cardiometabolic, and hormonal outcomes. Breast Cancer Research and Treatment. 205(2). 257–266. 13 indexed citations
4.
Kuperman, Gilad J., Eric J. Sherman, Alan L. Ho, et al.. (2024). Performance of a trained large language model to provide clinical trial recommendation in a head and neck cancer population.. Journal of Clinical Oncology. 42(16_suppl). 11081–11081. 1 indexed citations
5.
Desîlets, Antoine, David G. Pfister, Winston Wong, et al.. (2023). A phase 1 study of concurrent cabozantinib and cetuximab in recurrent or metastatic head and neck squamous cell cancer.. Journal of Clinical Oncology. 41(16_suppl). 6025–6025. 2 indexed citations
6.
Campbell, Thomas M., Eva Culakova, Nellie Wixom, et al.. (2023). Abstract P5-07-07: Feasibility of a Whole-Food, Plant-Based Intervention Among Women with Metastatic Breast Cancer and its Effect on Patient-Reported Outcomes. Cancer Research. 83(5_Supplement). P5–7.
7.
Dunn, Lara, Eric J. Sherman, Alan L. Ho, et al.. (2023). LookUpTrials: Assessment of an artificial intelligence-powered mobile application to engage oncology providers in clinical trials.. JCO Global Oncology. 9(Supplement_1). 111–111. 1 indexed citations
8.
Sherman, Eric J., Anuja Kriplani, James Fetten, et al.. (2023). A phase II study of lenvatinib plus pembrolizumab in patients with progressive, recurrent/metastatic adenoid cystic carcinoma.. Journal of Clinical Oncology. 41(16_suppl). 6048–6048. 7 indexed citations
9.
10.
Kang, Jung Julie, Yao Yu, Linda Chen, et al.. (2022). Consensuses, controversies, and future directions in treatment deintensification for human papillomavirus‐associated oropharyngeal cancer. CA A Cancer Journal for Clinicians. 73(2). 164–197. 39 indexed citations
11.
Burman, Bharat, Eric J. Sherman, Anuja Kriplani, et al.. (2020). Radioiodine (RAI) in combination with durvalumab for recurrent/metastatic thyroid cancers.. Journal of Clinical Oncology. 38(15_suppl). 6587–6587. 3 indexed citations
12.
Tchekmedyian, Vatche, Alan L. Ho, Lara Dunn, et al.. (2019). A retrospective analysis of cisplatin dosing strategies when used with radiation on outcomes in head and neck squamous cell carcinoma of the oropharynx.. Journal of Clinical Oncology. 37(15_suppl). 6079–6079. 1 indexed citations
13.
Fetten, James, et al.. (2006). Idiopathic Hypereosinophilic Syndrome: A Rare but Fatal Condition Presenting with Common Symptoms. Southern Medical Journal. 99(2). 188–189. 4 indexed citations
14.
Lichtman, Stuart M., Steven L. Allen, Daniel R. Budman, et al.. (1999). Acquired factor VIII inhibitors?successful treatment with an oral outpatient regimen. American Journal of Hematology. 60(1). 70–71. 24 indexed citations
15.
16.
Ito, Koichi, James Fetten, Houman Khalili, et al.. (1997). Oligoclonality of CD8+ T Cells in Breast Cancer Patients. Molecular Medicine. 3(12). 836–851. 11 indexed citations
17.
Fetten, James, et al.. (1996). Symptomatic Improvement Associated With Combined Estramustine and Vinblastine Chemotherapy for Metastatic Prostate Cancer. American Journal of Clinical Oncology. 19(6). 581–583. 16 indexed citations
18.
Fetten, James, Nathan H. Roy, & Eli Gilboa. (1991). A frameshift mutation at the NH2 terminus of the nucleoprotein gene does not affect generation of cytotoxic T lymphocyte epitopes. The Journal of Immunology. 147(8). 2697–2705. 42 indexed citations
19.
Kaplan, Mark H., William W. Hall, Myron Susin, et al.. (1991). Syndrome of severe skin disease, eosinophilia, and dermatopathic lymphadenopathy in patients with HTLV-II complicating human immunodeficiency virus infection. The American Journal of Medicine. 91(3). 300–309. 46 indexed citations
20.
Pizzarello, Roy A., Mitchell Goldman, James Fetten, et al.. (1985). Tumor of the heart diagnosed by magnetic resonance imaging. Journal of the American College of Cardiology. 5(4). 989–991. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paresh Jain Breakdown of academic impact, for papers by Tibor Füle Breakdown of academic impact, for papers by D. Rontogianni Breakdown of academic impact, for papers by Antonio Ramponi Breakdown of academic impact, for papers by Katie Fain Breakdown of academic impact, for papers by Bettien M. van Hemel Breakdown of academic impact, for papers by R Jlidi Breakdown of academic impact, for papers by Ren‐Ching Wang Breakdown of academic impact, for papers by Hans‐Georg Vogt Breakdown of academic impact, for papers by Carey Z. August
Rankless by CCL
2026